title: Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
abstract: The neurofibromatosis-2 (NF2) tumour-suppressor gene encodes an intracellular membrane-associated protein, called merlin, whose growth-suppressive function is dependent on its ability to form interactions through its intramolecular amino-terminal domain (NTD) and carboxy-terminal domain (CTD). Merlin phosphorylation plays a critical part in dictating merlin NTD/CTD interactions as well as in controlling binding to its effector proteins. Merlin is partially regulated by phosphorylation of Ser 518, such that hyperphosphorylated merlin is inactive and fails to form productive intramolecular and intermolecular interactions. Here, we show that the protein kinase Akt directly binds to and phosphorylates merlin on residues Thr 230 and Ser 315, which abolishes merlin NTD/CTD interactions and binding to merlin's effector protein PIKE-L and other binding partners. Furthermore, Akt-mediated phosphorylation leads to merlin degradation by ubiquitination. These studies demonstrate that Akt-mediated merlin phosphorylation regulates the function of merlin in the absence of an inactivating mutation.
authors: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.
authors: Xiaoling
authors: X
authors: Tang
authors: Sung-Wuk
authors: SW
authors: Jang
authors: Xuerong
authors: X
authors: Wang
authors: Zhixue
authors: Z
authors: Liu
authors: Scott M
authors: SM
authors: Bahr
authors: Shi-Yong
authors: SY
authors: Sun
authors: Daniel
authors: D
authors: Brat
authors: David H
authors: DH
authors: Gutmann
authors: Keqiang
authors: K
authors: Ye
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D000818:Animals; D015153:Blotting, Western; D045744:Cell Line, Tumor; D007150:Immunohistochemistry; D047468:Immunoprecipitation; D009154:Mutation; D025581:Neurofibromin 2 / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D011485:Protein Binding; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011499:Protein Processing, Post-Translational; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000378:metabolism; D013912:Threonine / Q000378:metabolism; D014452:Ubiquitins / Q000378:metabolism*; D000077191:Wortmannin
chemical_list: D000730:Androstadienes; D025581:Neurofibromin 2; D047428:Protein Kinase Inhibitors; D014452:Ubiquitins; D013912:Threonine; D012694:Serine; D051057:Proto-Oncogene Proteins c-akt; D000077191:Wortmannin